ArticlePloS one2018

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease.

Katsuyoshi Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.